Avadel Pharmaceuticals (AVDL) Payables: 2009-2022
Historic Payables for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Sep 2022 value amounting to $2.5 million.
- Avadel Pharmaceuticals' Payables fell 63.94% to $2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $23.5 million, marking a year-over-year increase of 32.54%. This contributed to the annual value of $7.7 million for FY2021, which is 161.72% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Payables of $2.5 million as of Q3 2022, which was down 66.12% from $7.3 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Payables registered a high of $15.9 million during Q1 2018, and its lowest value of $2.5 million during Q3 2022.
- In the last 3 years, Avadel Pharmaceuticals' Payables had a median value of $5.1 million in 2021 and averaged $5.1 million.
- Its Payables has fluctuated over the past 5 years, first tumbled by 73.91% in 2019, then spiked by 161.72% in 2021.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Payables stood at $3.5 million in 2018, then spiked by 74.14% to $6.1 million in 2019, then tumbled by 51.90% to $2.9 million in 2020, then skyrocketed by 161.72% to $7.7 million in 2021, then plummeted by 63.94% to $2.5 million in 2022.
- Its Payables was $2.5 million in Q3 2022, compared to $7.3 million in Q2 2022 and $6.0 million in Q1 2022.